Gentex (GNTX) Receives Bullish UBS Estimate Amid Strong Auto Results

UBS has raised Gentex's (GNTX) price target from $21 to $23, maintaining a Neutral rating. The firm expects strong auto sector performance but cautions on valuation. Analysts predict an average target price of $26.90, implying a 16.56% upside, and an estimated GF Value of $38.30, suggesting a 65.94% upside. Gentex reported Q1 net sales of $576.8 million, down from $590.2 million last year, and revenue guidance for 2025 at $2.1-$2.2 billion.

UBS has adjusted Gentex's (NASDAQ: GNTX) price target from $21 to $23, maintaining a Neutral rating. The investment bank anticipates robust performance in the auto sector but expresses caution regarding valuation. Analysts predict an average target price of $26.90, implying a 16.56% upside, and an estimated GF Value of $38.30, suggesting a 65.94% upside.

Gentex reported Q1 net sales of $576.8 million, down from $590.2 million last year. The company provided revenue guidance for 2025 at $2.1-$2.2 billion. Despite the decrease in Q1 sales, Gentex's financial performance remains strong, with a net margin of 17.01% and a return on equity of 16.11%.

The stock has experienced a 0.31% downside from its current price, with a consensus rating of "Hold" and a consensus price target of $28.28. Institutional investors hold 86.76% of the stock, with notable increases in stakes by Vanguard Group Inc., Wellington Management Group LLP, Burgundy Asset Management Ltd., JPMorgan Chase & Co., and Ariel Investments LLC.

Gentex designs, develops, manufactures, and markets digital vision, connected car, dimmable glass, and fire protection products. The company operates through Automotive Products and Other segments, serving original equipment manufacturers, automotive suppliers, and various aftermarket and accessory customers.

References:
[1] https://www.marketbeat.com/instant-alerts/gentex-nasdaqgntx-price-target-raised-to-2300-at-ubs-group-2025-07-14/
[2] https://www.marketscreener.com/quote/stock/GENTEX-CORPORATION-9464/news/UBS-Adjusts-Price-Target-on-Gentex-to-23-From-21-Keeps-Neutral-Rating-50502743/